Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Sernova Corp SEOVF


Primary Symbol: T.SVA

Healthcare Biotechnology
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch... see more

Recent & Breaking News (TSX:SVA)

2020 - The Emergence of Significant Scientific Medical Advances Where to Watch Next - Regenerative Medicine

TheNewsWire March 8, 2021

Sernova Announces Closing of C$23 Million Bought Deal Financing Including Full Exercise of Over-Allotment Option

TheNewsWire March 1, 2021

Sernova Corp. Selected for the TSX Venture Stock Exchange's 2021 Venture 50 List of Top Performing Listed Companies

TheNewsWire February 25, 2021

Sernova Obtains Final Prospectus Receipt for $20 Million Bought Deal

TheNewsWire February 24, 2021

Sernova Announces Second Annual Data Safety Monitoring Board Review of its Diabetes Cell Pouch System(tm) Clinical Trial and Recommendation for Protocol Continuation

TheNewsWire February 18, 2021

2020 - The Emergence of Significant Scientific Medical Advances Where to Watch Next - Regenerative Medicine

TheNewsWire February 10, 2021

BTV News Alert Video: Sernova Corp. - A Functional Cure for Type I Diabetes

Newsfile February 5, 2021

IIROC Trading Resumption - SVA

Canada NewsWire February 4, 2021

Sernova Upsizes Previously Announced Bought Deal Public Offering to C$20 Million

Canada NewsWire February 4, 2021

IIROC Trading Halt - SVA

Canada NewsWire February 4, 2021

Sernova Shares Accepted for Trading on the Electronic Trading Platform Xetra in Germany

TheNewsWire February 4, 2021

Sernova Corp. Announces C$10 Million Bought Deal Offering of Units

Canada NewsWire February 3, 2021

Sernova's Collaborator to Present Cell Pouch(TM) Thyroid Transplant Study Results at the American Association of Endocrine Surgeons 2021 Annual Meeting

TheNewsWire February 3, 2021

(RADIO INTERVIEW) Sernova Continues to Draw Media Attention: Global News London Goes In-Depth with Dr. Philip Toleikis

TheNewsWire February 2, 2021

Sernova Announces Collaboration Agreements with Multiple Pharmaceutical Industry Leaders

TheNewsWire January 28, 2021

Sernova Announces Warrants Exercise for Proceeds of $4.3 Million and Early Conversion of Debenture

TheNewsWire January 25, 2021

Sernova CEO to Present Regenerative Medicine Therapeutics Platform Update at the 2021 Cell & Gene Therapy Meeting on the Med

TheNewsWire January 21, 2021

Sernova’s (TSXV:SVA) clinical trials look hopeful

Brieanna McCutcheon  January 18, 2021

Sernova Principal Investigator Presents Additional Positive Preliminary Safety and Efficacy Data from Ongoing U.S. Phase I/II Cell Pouch Clinical Trial for Type-1 Diabetes

TheNewsWire January 18, 2021

IIROC Trading Resumption - SVA

Canada NewsWire January 15, 2021